LA JOLLA, Calif., July 10, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe...
LA JOLLA, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to...
EQUATE Phase 1b/2 trial in acute graft-versus-host disease (aGVHD) ongoing with data expected in 1Q 2020 On track to initiate Phase 1b proof-of-concept trials of itolizumab (EQ001) in...
Serves Approximately 7.5 Million Customers in 33 States; Expects $400 Million in Annual Synergies MONROE, La., July 1 /PRNewswire-FirstCall/ -- CenturyTel, Inc. (NYSE:CTL) and Embarq Corporation...
Transaction Has Now Received All Necessary Approvals MONROE, La. and OVERLAND PARK, Kan., June 25 /PRNewswire-FirstCall/ -- CenturyTel, Inc. (NYSE:CTL) and Embarq Corporation (NYSE:EQ) today...
The Way Forward Webinar Series Presents Living in the Age of Transparency: Security and Your Small Business OVERLAND PARK, Kan., June 15 /PRNewswire-FirstCall/ -- EMBARQ is pleased to present...
In the news release, EMBARQ Supports Small Business Owners With Free Webinar Series, issued earlier today by EMBARQ over PR Newswire, we are advised by the company that the first paragraph, first...
The Way Forward Webinar Series Presents Living in the Age of Transparency: Security and Your Small Business OVERLAND PARK, Kan., June 15 /PRNewswire-FirstCall/ -- EMBARQ is pleased to present...
TALLAHASSEE, Fla., June 5 /PRNewswire-FirstCall/ -- Three Florida counties today announced their participation in a Next Generation E911 network being deployed by EMBARQ. The new services offer...
Legacy brands to be used during transitional period MONROE, La. and OVERLAND PARK, Kan., June 2 /PRNewswire-FirstCall/ -- CenturyTel, Inc. (NYSE:CTL) and EMBARQ Corporation (NYSE:EQ) today...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約